Ocugen, Inc. entered into an underwriting agreement to issue and sell 30 million shares of common stock at a price of $0.50 per share, with an option for the underwriter to purchase additional shares. The offering is expected to close on May 26, 2023, and the net proceeds are estimated to be approximately $14.8 million.